Outcome ofStaphylococcus aureusBacteremia in Patients with Eradicable Foci versus Noneradicable Foci
Bacteremia
DOI:
10.1086/377540
Publication Date:
2003-09-05T16:19:28Z
AUTHORS (8)
ABSTRACT
To determine the outcome of Staphylococcus aureus bacteremia (SAB) on mortality, including impact methicillin resistance and an initial delay (< or =48 h) appropriate antibiotics, a retrospective cohort study 238 patients with SAB was performed. By logistic regression, noneradicable noneradicated foci, underlying cirrhosis, cancer were found to be independent predictors mortality. In eradicable there no significant differences in associated mortality rate between methicillin-resistant (11%) methicillin-susceptible (13%), inappropriate (13%) (10%) empirical therapy, respectively (P=.79 P=.78, respectively). it that, subgroup cirrhosis (odds ratio [OR], 3.1) (OR, 2.4) independently
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (18)
CITATIONS (113)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....